Altered circulating memory T cells in vitiligo cases followed NB-UVB therapy

Area of Science:

• Immunodermatology
• Autoimmune disease research
• T cell subset analysis

Background:

• Vitiligo is an autoimmune condition causing melanocyte loss.
• T cell subsets, including memory T cells, are implicated in vitiligo pathogenesis.

Purpose of the Study:

• To quantify CD4+ and CD8+ memory T cell subsets in vitiligo patients' blood.
• To assess changes in these T cell subsets after narrowband ultraviolet B (NB-UVB) therapy.

Main Methods:

• Flow cytometry was used to analyze T cell subsets (TCM and TEM) in 33 vitiligo patients and 16 healthy controls.
• Peripheral blood levels of related chemokines were also measured.

Main Results:

• Vitiligo patients showed reduced CD4+ and CD8+ central memory T (TCM) cell counts, with higher levels in active disease.
• NB-UVB therapy significantly decreased CD4+ and CD8+ TCM frequencies and CXCL9/CXCL10 chemokine levels in vitiligo patients.

Conclusions:

• NB-UVB therapy may exert immunosuppressive effects by reducing circulating memory T cells.
• CXCL9 and CXCL10 chemokines appear to mediate the homing of T cells to skin lesions.
• Targeting these chemokines could offer new therapeutic strategies for vitiligo.